Global Prostate Cancer Diagnostics Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Prostate Cancer Diagnostics Market Research Report 2023(Status and Outlook)



Report Overview

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

The Global Prostate Cancer Diagnostics Market Size was estimated at USD 13430.00 million in 2022 and is projected to reach USD 22719.95 million by 2029, exhibiting a CAGR of 7.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Prostate Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Prostate Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Prostate Cancer Diagnostics market in any manner.

Global Prostate Cancer Diagnostics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

OPKO

Genomic Health

Abbott

Beckman Coulter

Siemens Healthcare

bioMeriux

Roche

MDx Health

DiaSorin

Myriad Genetics

Ambry Genetics

Market Segmentation (by Type)

Tumor Biomarker Tests

Imaging

Biopsy

Other

Market Segmentation (by Application)

Aquaculture

Livestock

Poultry

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Prostate Cancer Diagnostics Market

Overview of the regional outlook of the Prostate Cancer Diagnostics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prostate Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Prostate Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Prostate Cancer Diagnostics Segment by Type
1.2.2 Prostate Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Prostate Cancer Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Prostate Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Prostate Cancer Diagnostics Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Prostate Cancer Diagnostics Market Competitive Landscape
3.1 Global Prostate Cancer Diagnostics Sales by Manufacturers (2018-2023)
3.2 Global Prostate Cancer Diagnostics Revenue Market Share by Manufacturers (2018-2023)
3.3 Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Prostate Cancer Diagnostics Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Prostate Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Prostate Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Prostate Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Prostate Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Prostate Cancer Diagnostics Industry Chain Analysis
4.1 Prostate Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Prostate Cancer Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Prostate Cancer Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prostate Cancer Diagnostics Sales Market Share by Type (2018-2023)
6.3 Global Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
6.4 Global Prostate Cancer Diagnostics Price by Type (2018-2023)
7 Prostate Cancer Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prostate Cancer Diagnostics Market Sales by Application (2018-2023)
7.3 Global Prostate Cancer Diagnostics Market Size (M USD) by Application (2018-2023)
7.4 Global Prostate Cancer Diagnostics Sales Growth Rate by Application (2018-2023)
8 Prostate Cancer Diagnostics Market Segmentation by Region
8.1 Global Prostate Cancer Diagnostics Sales by Region
8.1.1 Global Prostate Cancer Diagnostics Sales by Region
8.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Prostate Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Prostate Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Prostate Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Prostate Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 OPKO
9.1.1 OPKO Prostate Cancer Diagnostics Basic Information
9.1.2 OPKO Prostate Cancer Diagnostics Product Overview
9.1.3 OPKO Prostate Cancer Diagnostics Product Market Performance
9.1.4 OPKO Business Overview
9.1.5 OPKO Prostate Cancer Diagnostics SWOT Analysis
9.1.6 OPKO Recent Developments
9.2 Genomic Health
9.2.1 Genomic Health Prostate Cancer Diagnostics Basic Information
9.2.2 Genomic Health Prostate Cancer Diagnostics Product Overview
9.2.3 Genomic Health Prostate Cancer Diagnostics Product Market Performance
9.2.4 Genomic Health Business Overview
9.2.5 Genomic Health Prostate Cancer Diagnostics SWOT Analysis
9.2.6 Genomic Health Recent Developments
9.3 Abbott
9.3.1 Abbott Prostate Cancer Diagnostics Basic Information
9.3.2 Abbott Prostate Cancer Diagnostics Product Overview
9.3.3 Abbott Prostate Cancer Diagnostics Product Market Performance
9.3.4 Abbott Business Overview
9.3.5 Abbott Prostate Cancer Diagnostics SWOT Analysis
9.3.6 Abbott Recent Developments
9.4 Beckman Coulter
9.4.1 Beckman Coulter Prostate Cancer Diagnostics Basic Information
9.4.2 Beckman Coulter Prostate Cancer Diagnostics Product Overview
9.4.3 Beckman Coulter Prostate Cancer Diagnostics Product Market Performance
9.4.4 Beckman Coulter Business Overview
9.4.5 Beckman Coulter Prostate Cancer Diagnostics SWOT Analysis
9.4.6 Beckman Coulter Recent Developments
9.5 Siemens Healthcare
9.5.1 Siemens Healthcare Prostate Cancer Diagnostics Basic Information
9.5.2 Siemens Healthcare Prostate Cancer Diagnostics Product Overview
9.5.3 Siemens Healthcare Prostate Cancer Diagnostics Product Market Performance
9.5.4 Siemens Healthcare Business Overview
9.5.5 Siemens Healthcare Prostate Cancer Diagnostics SWOT Analysis
9.5.6 Siemens Healthcare Recent Developments
9.6 bioMeriux
9.6.1 bioMeriux Prostate Cancer Diagnostics Basic Information
9.6.2 bioMeriux Prostate Cancer Diagnostics Product Overview
9.6.3 bioMeriux Prostate Cancer Diagnostics Product Market Performance
9.6.4 bioMeriux Business Overview
9.6.5 bioMeriux Recent Developments
9.7 Roche
9.7.1 Roche Prostate Cancer Diagnostics Basic Information
9.7.2 Roche Prostate Cancer Diagnostics Product Overview
9.7.3 Roche Prostate Cancer Diagnostics Product Market Performance
9.7.4 Roche Business Overview
9.7.5 Roche Recent Developments
9.8 MDx Health
9.8.1 MDx Health Prostate Cancer Diagnostics Basic Information
9.8.2 MDx Health Prostate Cancer Diagnostics Product Overview
9.8.3 MDx Health Prostate Cancer Diagnostics Product Market Performance
9.8.4 MDx Health Business Overview
9.8.5 MDx Health Recent Developments
9.9 DiaSorin
9.9.1 DiaSorin Prostate Cancer Diagnostics Basic Information
9.9.2 DiaSorin Prostate Cancer Diagnostics Product Overview
9.9.3 DiaSorin Prostate Cancer Diagnostics Product Market Performance
9.9.4 DiaSorin Business Overview
9.9.5 DiaSorin Recent Developments
9.10 Myriad Genetics
9.10.1 Myriad Genetics Prostate Cancer Diagnostics Basic Information
9.10.2 Myriad Genetics Prostate Cancer Diagnostics Product Overview
9.10.3 Myriad Genetics Prostate Cancer Diagnostics Product Market Performance
9.10.4 Myriad Genetics Business Overview
9.10.5 Myriad Genetics Recent Developments
9.11 Ambry Genetics
9.11.1 Ambry Genetics Prostate Cancer Diagnostics Basic Information
9.11.2 Ambry Genetics Prostate Cancer Diagnostics Product Overview
9.11.3 Ambry Genetics Prostate Cancer Diagnostics Product Market Performance
9.11.4 Ambry Genetics Business Overview
9.11.5 Ambry Genetics Recent Developments
10 Prostate Cancer Diagnostics Market Forecast by Region
10.1 Global Prostate Cancer Diagnostics Market Size Forecast
10.2 Global Prostate Cancer Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Prostate Cancer Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Prostate Cancer Diagnostics Market Size Forecast by Region
10.2.4 South America Prostate Cancer Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Prostate Cancer Diagnostics by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Prostate Cancer Diagnostics Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Prostate Cancer Diagnostics by Type (2024-2029)
11.1.2 Global Prostate Cancer Diagnostics Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Prostate Cancer Diagnostics by Type (2024-2029)
11.2 Global Prostate Cancer Diagnostics Market Forecast by Application (2024-2029)
11.2.1 Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Prostate Cancer Diagnostics Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings